Home › Hidradenitis Suppurativa › Missouri
Hidradenitis Suppurativa clinical trials in Missouri
6 studies for Hidradenitis Suppurativa are looking for participants at sites in Missouri.
Cities in Missouri
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Washington University, St Louis
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US088, Saint Joseph
- Investigative Site US016, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, St Louis
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Oct 29, 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- University Health Dermatology- Site Number : 8400018, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07225569Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Washington University- Site Number : 8400010, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07170917Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Red River Research Partners, Bolivar
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 9, 2026 · NCT07049575From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.